Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;48(8):699-709.
doi: 10.1177/17531934231177425. Epub 2023 May 24.

Thalidomide upper limb embryopathy - pathogenesis, past and present management and future considerations

Affiliations
Review

Thalidomide upper limb embryopathy - pathogenesis, past and present management and future considerations

Neil Vargesson et al. J Hand Surg Eur Vol. 2023 Sep.

Abstract

This review article provides a comprehensive overview of thalidomide upper limb embryopathy including updates about its pathogenesis, a historical account of the management of the paediatric thalidomide patient, experience with management of the adult patient, as well as creating awareness about early onset age-related changes associated with limb differences. Despite its withdrawal from the market in November 1961, novel discoveries have meant thalidomide is licensed again and currently still in use to treat a variety of conditions, including inflammatory disorders and some cancers. Yet, if not used safely, thalidomide still has the potential to cause damage to the embryo. Recent work identifying thalidomide analogues that retain clinical benefits yet without the harmful effects are showing great promise. Understanding the problems thalidomide survivors face as they age can allow surgeons to support their unique healthcare issues and translate these principles of care to other congenital upper limb differences.

Keywords: Thalidomide; cereblon; embryopathy; radial dysplasia; reversed shoulder.

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Simple orthoses could help with daily activities.
Figure 2.
Figure 2.
A typical example of thalidomide-associated ‘phocomelia’. Note the presence of the scapula and clavicle. The hand has a major radial deficit and is attached to a short bone that has some features of a humerus.
Figure 3.
Figure 3.
(a) An adult thalidomide patient with bilateral radial dysplasia. (b) The right elbow joint, demonstrating a single bone articulation that can be compensated for by glenohumeral external rotation.
Figure 4.
Figure 4.
Radiological changes of the right shoulder joint showing severe glenoid dysplasia, with concave remodelling of the humeral head. This is due to constant excessive external rotation at the shoulder and has been described as a ‘natural reverse shoulder replacement’.
Figure 5.
Figure 5.
(a) This patient with bilateral radial dysplasia presented with severe median nerve compression in his right hand. Note the scaphoid hypoplasia on the right wrist indicating a mild radial dysplasia with thumb hypoplasia. (b) Ultrasound images showed an enlarged median nerve proximal to the carpal tunnel (yellow dotted line). Such imaging is helpful when planning surgery as the position of the nerve may be abnormal and (c) The left wrist was also scanned but no median nerve could be seen convincingly.

Similar articles

Cited by

References

    1. Asatsuma-Okumura T, Ando H, Simone MD, et al.. P63 is a cereblon substrate involved in thalidomide teratogenicity. Nat Chem Biol. 2019, 15: 1077–84. - PubMed
    1. Asatsuma-Okumura T, Ito T, Handa H. Molecular mechanisms of the teratogenic effects of thalidomide. Pharmaceuticals (Basel). 2020, 13: 95. - PMC - PubMed
    1. Bauer KS, Dixon SC, Figg WD. Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent. Biochem Pharmacol. 1998, 55: 1827–34. - PubMed
    1. Beedie SL, Huang PA, Harris EM, et al.. Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs. FASEB J. 2020, 34: 11395–404. - PMC - PubMed
    1. Beedie SL, Rore HM, Barnett S, et al.. In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems. Oncotarget. 2016, 7: 33237–45. - PMC - PubMed